BOSTON, Dec. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Deep Origin on a 4.5-year project funded by the Advanced Research Projects Agency for Health (ARPA ...

Every fall, the University of Virginia’s beloved Pratt ginkgo puts on a show. Long after most trees have dropped their leaves, this beauty hangs onto its soft green canopy until, almost overnight, it ...

Tests on a tissue sample confirm a researchers aboard a vessel near Baja California were they first to observe the species alive Kelli Bender is the Pets Editor at PEOPLE. She has been working at ...

Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build a standardized framework for ...

BOSTON — Nov. 20, 2025 — Ginkgo Bioworks (NYSE: DNA) today announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. One in five adults over age 60 takes fish oil, a ...

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It ...

Includes $0.3 million and $0.2 million in employer payroll taxes for the three months ended September 30, 2025 and 2024, respectively, and $0.9 million and $2.9 million for the nine months ended ...

A ginkgo tree at the California state Capitol was fenced off this month because its putrid fruit was both a slip and a sniff hazard. Incidentally, the berries — technically seeds with a casing — do ...

STATEN ISLAND, N.Y. — As New York heads into peak foliage season, the crisp autumn air carries a signature scent — the unmistakable stink of the ginkgo. That pungent perfume is Mother Nature’s ...

Ginkgo Bioworks' shares have rallied tremendously, and Q2 results showed a headline revenue beat with no upward guidance revision. Biosecurity segment guidance was cut, and overall revenue estimates ...